Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism (Q40089946)

17 September 2017

Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism (English)

1 reference

17 September 2017

1 reference

14

Anil K Sood

1 reference

17 September 2017

Monique B Nilsson

1

1 reference

17 September 2017

Guillermo Armaiz-Pena

2

1 reference

17 September 2017

Rie Takahashi

3

1 reference

17 September 2017

Yvonne G Lin

4

1 reference

17 September 2017

Jose Trevino

5

1 reference

17 September 2017

Yang Li

6

1 reference

17 September 2017

Nicholas Jennings

7

1 reference

17 September 2017

Jesusa Arevalo

8

1 reference

17 September 2017

Susan K Lutgendorf

9

1 reference

17 September 2017

Gary E Gallick

10

1 reference

17 September 2017

Angela M Sanguino

11

1 reference

17 September 2017

Gabriel Lopez-Berestein

12

1 reference

17 September 2017

Steven W Cole

13

1 reference

17 September 2017

language of work or name

English

0 references

publication date

23 August 2007

1 reference

Journal of Biological Chemistry

17 September 2017

1 reference

17 September 2017

282

1 reference

17 September 2017

41

1 reference

17 September 2017

29919-29926

1 reference

Sex, stress and the hippocampus: allostasis, allostatic load and the aging process

17 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

The influence of bio-behavioural factors on tumour biology: pathways and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Mouse Mammary Tumors: Alteration of Incidence as Apparent Function of Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Chronic stress accelerates ultraviolet-induced cutaneous carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Chronic stress and susceptibility to skin cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Stress-induced immune dysfunction: implications for health

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Social support, psychological distress, and natural killer cell activity in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Role of angiogenesis in tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Interleukin-6 serum levels in patients with gynecological tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Chronic stress and age-related increases in the proinflammatory cytokine IL-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Epinephrine infusion increases adipose interleukin-6 gene expression and systemic levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Norepinephrine-induced interleukin-6 increase in rat hearts: differential signal transduction in myocytes and non-myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Changes in sympathetic nerve activity of the mammalian ovary during a normal estrous cycle and in polycystic ovary syndrome: Studies on norepinephrine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Release of norepinephrine from human ovary: coupling to steroidogenic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Exposure to cAMP and beta-adrenergic stimulation recruits Ca(V)3 T-type channels in rat chromaffin cells through Epac cAMP-receptor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Epac- and Ca2+ -controlled activation of Ras and extracellular signal-regulated kinases by Gs-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Norepinephrine induces vascular endothelial growth factor gene expression in brown adipocytes through a beta -adrenoreceptor/cAMP/protein kinase A pathway involving Src but independently of Erk1/2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

MAP kinase stimulation by cAMP does not require RAP1 but SRC family kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Src tyrosine kinase is a novel direct effector of G proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611539200

21 January 2018

Identifiers

DOI

10.1074/JBC.M611539200

1 reference

17 September 2017

1 reference